HUMATIN

This brand name is authorized in Austria, Canada, Estonia, Italy, Malta, Spain.

Active ingredients

The drug HUMATIN contains one active pharmaceutical ingredient (API):

1	Paromomycin UNII 845NU6GJPS - PAROMOMYCIN SULFATE
	Paromomycin is an aminoglycoside antibiotic derived from Streptomyces rimosus var paromomycinus, with amebicidal and antibacterial activity. Paromomycin binds specifically to the RNA oligonucleotide at the A site of bacterial 30S ribosomes, thereby causing misreading and premature termination of translation, thereby leading to inhibition of protein synthesis followed by cell death.
	Read more about Paromomycin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
HUMATIN Capsule	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A07AA06	Paromomycin	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07A Intestinal antiinfectives → A07AA Antibiotics
Discover more medicines within A07AA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02078759
EE	Ravimiamet	1754311, 1754502
ES	Centro de información online de medicamentos de la AEMPS	36795
IT	Agenzia del Farmaco	016531016, 039333012
MT	Medicines Authority	AA565/47501